ArticleScientific reports2026
Impact of climatic factors on trigeminal neuralgia and facial neuropathy in primary care during a fourteen-year time-series study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trigeminal neuralgia and related facial neuropathic pain are severe disorders that are characterized by paroxysmal facial pain. Although meteorological factors have been associated with migraine and musculoskeletal pain, their role in trigeminal neuropathic pain remains poorly understood. Biometeorological mechanisms suggest that climatic variables may modulate symptom perception and healthcare-seeking behavior rather than disease incidence. The aim of this study was to evaluate the association between climatic variables and risk of seeking primary care for trigeminal neuralgia and facial neuropathy over a 14-year period in a Mediterranean population. This retrospective cohort study was conducted using electronic health records from three primary care centers in Madrid (Spain) between 2010 and 2023. All consultations coded as trigeminal neuralgia (ICPC-2 N03) or facial neuropathy (ICPC-2 N89.02) were included in the study. Individual consultation events were linked to meteorological data from the Spanish State Meteorological Agency. A piecewise additive exponential event-based model fitted with a negative binomial distribution was applied to estimate hazard ratios (HR), allowing flexible modeling of non-linear climatic effects and long-term temporal trends in a low-event-density, time-to-event context. A total of 246 consultations were identified (mean age 66.6 ± 14.6 years; 66.7% female). Increased hours of sunshine were independently associated with a higher risk of seeking medical attention for trigeminal neuralgia (HR = 1.081 per additional hour; 95% CI, 1.016–1.150). A significant non-linear association with ambient temperature was observed, with higher consultation risk at temperatures below approximately 10 °C and stabilization thereafter. The long-term temporal trend remains largely stable until there is a significant increase in consultation risk during the post-COVID-19 period (2021–2023). In this population-based primary care study, specific climatic factors, particularly sunlight exposure and low ambient temperature, were associated with the risk of seeking medical attention for trigeminal neuralgia and facial neuropathic pain. These findings suggest that climatic variables may act as modulators of healthcare utilization rather than primary drivers of disease incidence. Intrinsic neuropathological mechanisms remain central to trigeminal neuralgia pathophysiology, whereas environmental factors may influence symptom perception and care-seeking behavior in susceptible individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.